SUMMARY
INTRODUCTION
The appropriate differentiation of naive T helper cells into functionally specialized effector lineages is critical for generating productive immune responses against different types of pathogens. T helper 1 (Th1) cells are required for immunity to intracellular pathogens and develop from naive precursors via a multistep mechanism involving sequential activation of the transcription factors STAT1, T-bet, and STAT4. Initially, T cell receptor (TCR) stimulation in conjunction with STAT1 activation by cytokines such as IFN-g induce low-level expression of the transcription factor T-bet, which in turn drives expression of the inducible IL-12 receptor component IL-12Rb2 (Afkarian et al., 2002; Mullen et al., 2001 ). This allows the cells to undergo IL-12-dependent activation of STAT4, whereupon STAT4 and T-bet act independently and synergistically to drive expression of the signature inflammatory cytokine IFN-g, as well as other genes required for the proper function of Th1 cells (Thieu et al., 2008; Wei et al., 2010) .
In addition to effector Th subsets, Foxp3 + regulatory T (Treg) cells comprise a distinct CD4 + T cell lineage important for dampening inflammation and preventing autoimmunity (Sakaguchi et al., 2008) . Treg cell differentiation occurs primarily in the thymus, where developing T cells upregulate Foxp3 upon recognition of self-antigen and stimulation with IL-2 or IL-15. Thus, the TCR repertoire of Treg cells is believed to be heavily biased toward autoreactivity (Lio and Hsieh, 2011) . Like conventional CD4 + Th cells, Treg cells can be subdivided into distinct subsets on the basis of differential expression of homing receptors and activation markers (Huehn et al., 2004; Min et al., 2007) , and multiple functional mechanisms of suppression have been ascribed to Treg cells (Vignali et al., 2008; Shevach, 2009; Tang and Bluestone, 2008) . Indeed, the ability of Treg cells to control different types of Th cell responses depends on their expression of specific Th cell-associated transcription factors Koch et al., 2009; Zheng et al., 2009) . For example, although T-bet is considered the ''master regulator'' of Th1 cell differentiation, Treg cells selectively upregulate T-bet during type 1 inflammatory responses in vivo, and T-betdeficient Treg cells display diminished expression of the Th1 cell-associated chemokine receptor CXCR3 and fail to rescue Foxp3-deficient mice from Th1 cell-mediated inflammatory disease (Koch et al., 2009 ). Thus, the phenotypic and functional heterogeneity of Treg cells helps ensure that they can modulate different types of immune responses in both lymphoid and nonlymphoid tissue sites (Campbell and Koch, 2011) .
The diversity of peripheral Treg cells suggests that they alter their migratory, functional, and homeostatic properties in response to contextual cues from the immune environment. However, the mechanisms guiding the development of specialized Treg cell subsets, and the ways in which they mirror and diverge from the comparatively well-characterized pathways of effector T cell differentiation, have not been extensively explored. In addition, the autoreactivity of Treg cells presents a significant danger if they were to acquire proinflammatory effector functions. Thus, strict mechanisms that limit the functional reprogramming of Treg cells during strong inflammatory responses are thought to exist. For instance, despite upregulating T-bet during Th1 cell inflammatory responses, T-bet + Treg cells do not typically produce IFN-g (Koch et al., 2009 ). However, IFN-g-producing Treg cells have been observed during the dysregulated immune responses associated with autoimmune disease or infection-induced immunopathologies (Oldenhove et al., 2009; Zhao et al., 2011) . This has led to the notion that Treg cells retain a considerable degree of functional plasticity (Zhou et al., 2009) , although this notion has been questioned in subsequent studies (Rubtsov et al., 2010; Miyao et al., 2012) . In this study, we examined the cellular and molecular pathway leading to the upregulation of T-bet by Treg cells and explored the mechanisms limiting their ability to acquire proinflammatory effector functions in Th1 cell-polarizing inflammatory environments. We demonstrate that activation of STAT1 by effector T cell-derived IFN-g induced T-bet expression in Treg cells. However, delayed induction of the IL-12 receptor component IL-12 Rb2 prevented Treg cells from completing STAT4-dependent Th1 cell differentiation during acute type 1 inflammatory responses. Thus, abortive Th1 cell differentiation driven by activation of STAT1, but not STAT4, results in the generation of functionally specialized T-bet + Treg cells that effectively modulate Th1 cell responses without acquiring proinflammatory effector functions.
RESULTS

STAT1-Dependent Expression of T-bet by Treg Cells
We recently identified and characterized a population of T-bet + CXCR3 + Treg cells that express elevated amounts of Il10 and that are important for regulating strong Th1 cell responses (Koch et al., 2009 Figure 1B ).
Treg cell expression of T-bet and CXCR3 is reduced in mice lacking the STAT1-activating IFN-g receptor (IFN-gR [Koch et al., 2009] Figure S2 ), further 
Treg cells in the CNS showed decreased IL-10 production at day 19 ( Figure 1D ), a late time point associated with Treg cellmediated amelioration of disease (Korn et al., 2007; McGeachy et al., 2005) . Thus, even during strong inflammatory responses associated with EAE, IFN-g promotes the functional specialization of Treg cells by controlling the expression of molecules such as CXCR3 and IL-10 that are critical for Treg cell-mediated disease suppression (McGeachy et al., 2005; Mü ller et al., 2007) . 
IL-12R Signaling Is Dispensable for the Development of T-bet + Treg Cells
In addition to the STAT1 activating cytokines, IL-12 has an essential role in Th1 cell differentiation (Trinchieri, 2003; Hsieh et al., 1993; Manetti et al., 1993) , and activation of STAT4 via the IL-12 receptor is necessary for expression of genes required for Th1 cell function (Thieu et al., 2008; Wei et al., 2010) . However, Treg cell expression of T-bet and CXCR3 was unaltered in IL-12Rb2-deficient mice (Figures 3A and S2) , indicating that STAT4 activation via IL-12R is dispensable for the differentiation of T-bet + Treg cells.
Although most T cells express the IL-12 receptor subunit IL-12Rb1, naive CD4 + T cells lack expression of IL-12Rb2 and are not IL-12 responsive (Szabo et al., 1997) . Induction of IL12Rb2 downstream of STAT1 and T-bet is a key checkpoint in Th1 cell development (Afkarian et al., 2002; Mullen et al., 2001) . Indeed, whereas both Foxp3 + CXCR3 + Treg cells and Foxp3 
IL-12 Can Functionally Reprogram Treg Cells
Although IL-12 has been reported to induce IFN-g-production by Foxp3 + Treg cells in vitro, it does so inefficiently, with only $5% of CD4 + Foxp3 + cells producing IFN-g after activation for 3 days in the presence of IL-12 (Wei et al., 2009 ). Moreover, a recent study demonstrating that Foxp3 + cells contain a small population of effector T cells suggests that at least some of the observed IFN-g production could result from these contaminating cells (Miyao et al., 2012 Figure S5 ).
The stringent regulation of IL-12Rb2 expression in autoreactive Treg cells may serve as a tolerance mechanism that prevents them from undergoing IL-12-dependent functional differentiation and acquiring potentially dangerous proinflammatory properties such as the ability to produce IFN-g. Alternatively, the inability of Treg cells to produce IFN-g may result from direct inhibition of Ifng expression by Foxp3 or other Treg cell-specific repressive mechanisms. To determine how IL-12 receptor signaling functionally impacts Treg cells, we activated sorted CD4 We then cultured these cells with or without IL-12 for 3 additional days, examined their ability to produce IFN-g, and assessed their suppressive function in vitro. Despite the reported ability of Foxp3 to directly inhibit IFN-g expression (Ono et al., 2007) , IL-12 potently induced IFN-g production in both Foxp3 + and Foxp3 À cells that had been ''primed'' with IFN-g ( Figure 5A ). In addition, IL-12 treatment substantially reduced the ability of Treg cells to inhibit effector T cell proliferation ( Figure 5B (Way et al., 2007; Seki et al., 2002) , the Il12a and Il12b genes were strongly upregulated in the spleen within 1 day of infection, after which their expression was rapidly extinguished ( Figure 6A and data not shown). Moreover, direct ex vivo analysis of CD4 + Foxp3 À CD44 hi T cells (without any in vitro restimulation) showed that $25% of these effector T cells in the spleen were phospho(p)-STAT4 + on day 1 after infection and that a substantial fraction of the pSTAT4 + cells were also producing IFN-g ( Figures 6B and 6C ).
However, mirroring the sharp decline in IL-12 cytokine expression, the frequency of pSTAT4 + IFN-g-producing effector
T cells fell dramatically on days 2 and 3 after infection. By contrast, less than 5% of splenic Treg cells were pSTAT4 + directly ex vivo at any time point examined during infection (Figures 6B, middle, and 6C). Indeed, IL-12 responsiveness, as measured by the ability to phosphorylate STAT4 after in vitro IL-12 treatment, emerged in only a small fraction of Treg cells between days 3-5 postinfection, after production of IL-12 had ceased ( Figure 6B , right). Coincident with the robust IFN-g production by effector T cells, we observed a dramatic increase in STAT1 phosphorylation in Treg cells on days 1 and 2 postinfection ( Figure 7A) . Accordingly, expression of T-bet and CXCR3 was dramatically elevated in Treg cells from L. monocytogenes infected mice. However, consistent with their inability to respond to IL-12 early in infection, very few Treg cells acquired the ability to produce IFN-g ( Figure 7B ). To determine whether IL-12 receptor signaling is required for the small degree of IFN-g production by Treg cells during L. monocytogenes infection, we reconstituted Tcrb 
DISCUSSION
In this study, we examined how Treg cells respond to inflammatory cytokines produced during strong Th1 cell responses in vitro and in vivo. We define a mechanism whereby impaired upregulation of IL-12Rb2 causes Treg cells to undergo abortive Th1 cell differentiation driven by activation of STAT1 but not STAT4. This results in the phenotypic and functional specialization of Treg cells via induction of T-bet and prevents them from IL-12-dependent functional reprogramming leading to their acquisition of potentially harmful proinflammatory effector functions. Increasing evidence indicates that Treg cells both sense and respond to changes in the immune environment and that this is necessary for proper immunoregulation. For instance, IL-10-dependent activation of STAT3 is important for the ability of Treg cells to effectively restrain Th17 cell-mediated inflammatory responses (Chaudhry et al., 2011) . Additionally, Treg cell abundance is tightly linked to the size of the dendritic cell compartment, given that depletion or expansion of dendritic cells in vivo serves to reduce or augment Treg cell numbers, respectively (Darrasse-Jè ze et al., 2009). Treg cells are also sensitive to changes in the amount of IL-2 produced by CD4 +
Foxp3
À CD44 hi T cells, and this is thought to be a mechanism by which Treg cell abundance can be rapidly altered as the number of effector T cells fluctuates (Setoguchi et al., 2005 
Immunity Abortive Th1 Cell Differentiation of Treg Cells
Although STAT1 activation initiates Th1 cell development, IL-12-dependent STAT4 activation is required for full Th1 cell differentiation. Indeed, STAT4 and T-bet have distinct, yet overlapping functions in establishing the Th1 cell-specific gene expression program. For instance, STAT4 induces the high level of T-bet expression necessary for the terminal differentiation of Th1 effector cells, and activated STAT4 synergizes with T-bet to drive expression of IFN-g (Thieu et al., 2008; Mullen et al., 2001) . Similarly, IL-12 controls the level of T-bet expression in CD8 + effector T cells and dictates whether CD8 + T cells become ''short-lived effector cells'' or long-lived ''memory-precursor effector cells'' (Joshi et al., 2007) . Consistent with their lack of ex vivo IL-12 responsiveness, T-bet + CXCR3 + Treg cells express 5-to 10-fold less T-bet than fully differentiated Th1 cells and do not produce IFN-g (Koch et al., 2009) . Moreover, we show that they lack expression of other STAT4 regulated genes, and thus we conclude that these Treg cells have undergone a form of incomplete Th1 cell differentiation driven by activation of STAT1 but not STAT4.
Despite being a key checkpoint in Th1 cell development, the molecular control of Il12Rb2 expression is still poorly understood. Although its expression after STAT1 activation is T-bet dependent, it is unclear whether T-bet acts directly on the Il12rb2 locus. Notably, a number of IFN-g activation site (GAS) elements are found upstream of the Il12rb2 coding sequence, indicating that expression of this gene may be directly regulated by STAT1 (Letimier et al., 2007) . Moreover, IL-12-dependent STAT4 activation can feed-forward and enhance Il12rb2 expression (Becskei and Grusby, 2007) . In addition, TCR stimulation alone results in recruitment of the Brg1-containing BAF chromatin remodeling complex to the Il12rb2 locus, which promotes histone hyperacetylation and potentiates STAT-induced Il12rb2 expression (Letimier et al., 2007) . However, the presence of abundant H3K27me3 histone modifications at the Il12rb2 promoter probably acts to temporally delay IL-12Rb2 induction in Treg cells until H3K27 demethylases such as Jumonji 3 can be recruited and remove this chromatin mark (De Santa et al., 2007) . Although Foxp3 is a potent transcriptional repressor, it is not found at or near the Il12rb2 locus (Zheng et al., 2007; Marson et al., 2007) , and deletion of Foxp3 in established Treg cells does not result in Il12rb2 upregulation (Williams and Rudensky, 2007) . In addition, IL-12 can potently induce IFN-g production from TGF-b-induced Treg cells in vitro (Feng et al., 2011) , which are believed to retain a greater degree of phenotypic and functional plasticity than the in vivo-derived natural Treg cells we examined. Thus, repression of Il12rb2 expression appears to be part of the Foxp3-independent program of Treg cell differentiation, and further studies are needed to establish the precise molecular mechanisms that regulate Il12rb2 expression in effector and regulatory T cells.
During acute inflammation, cells of the innate immune system transiently produce IL-12 after pathogen recognition, and we showed that delayed induction of IL-12Rb2 prevented Treg cells from sensing and responding to IL-12 during acute L. monocytogenes infection. However, acquisition of IL-12 responsiveness after prolonged STAT1 activation predicts that Treg cells would be more susceptible to functional reprogramming during sustained or dysregulated inflammatory responses. Accordingly, we observed that IL-12 potentiated production of IFN-g and decreased the suppressive function of IFN-g pretreated Treg cells. Moreover, unlike the transient IL-12 production we observed during L. monocytogenes infection, sustained IL-12 production during the lethal intestinal inflammation caused by oral infection with Toxoplasma is associated with functional reprogramming of Treg cells into IFN-g-producing Th1-like cells (Oldenhove et al., 2009) , and IFN-g-producing Treg cells are also found in the CNS during chronic corona-virus-induced encephalomyelitis (Zhao et al., 2011) . Finally, consistent with our results indicating that sustained STAT1 activation renders Treg cells susceptible to IL-12-mediated functional reprogramming, IFN-g production is observed in Treg cells displaying elevated STAT1 activation due to loss of the microRNA miR-146a 
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Abortive Th1 Cell Differentiation of Treg Cells (Lu et al., 2010) . Thus, although Foxp3 has been reported to inhibit expression of IFN-g by Treg cells (Ono et al., 2007) , IL-12 appears to be sufficient to overcome this blockade, and impaired IL-12Rb2 induction helps limit the functional reprogramming of Treg cells during Th1 cell inflammation. This also provides a molecular mechanism that helps reconcile conflicting data regarding the susceptibility of Treg cells to functional reprogramming in resolving versus chronic inflammatory conditions (Oldenhove et al., 2009; Rubtsov et al., 2010; Zhao et al., 2011) . By demonstrating that cytokines produced by activated effector T cells can influence the specialization of Treg cells, our data help elucidate how immune homeostasis is maintained after the initiation of robust T cell responses. We also identify the regulated expression of IL-12Rb2 as a key checkpoint that functions to prevent Treg cells from obtaining proinflammatory effector functions and that may contribute to the ''functional plasticity'' of Treg cells observed during uncontrolled inflammation. Further examining how Treg cells respond to specific signals in the immune environment will provide new insights into how Treg cell activity is controlled during different types of immune responses, and is vital for developing and optimizing cellular and molecular therapies aimed at manipulating Treg cell activity in the contexts of autoimmunity, cancer, transplantation, and chronic infection. 
Cell Isolations
Lymphocytes were isolated from the spleens and lymph nodes (LNs) by tissue disruption with glass slides followed by filtration through a 100 mM filter. CNS lymphocytes were recovered from perfused animals by grinding brain and spinal cord tissue through a 100 mm filter with the plunger of a 5 mL syringe. Cells were pelleted by centrifugation at 3200 rpm for 15 min and resuspended in 6 mL of 37% Percoll (GE Healthcare). Cells were centrifuged again at 3200 rpm for 15 min (brake off) and lymphocytes were recovered after evacuation of the fatty supernatant. anti-CD3 (2C11; UCSF hybridoma core) and anti-CD28 (37.51; UCSF hybridoma core) in medium containing 500 units/mL rmIL-2. rmIFN-g, rmIL-27, and rmIL-12p70 were added to some cultures at 25 ng/mL as indicated. All cytokines used were from eBioscience or Biolegend. Cells were cultured for 72 hr at 37 C, at which point they were analyzed or removed from the CD3 and CD28 stimulus and cultured in fresh medium containing cytokines for 48-72 more hours at 37 C. In some assays, after 144 hr of culture, cells were washed and cultured for an additional 3 days with 500 units/mL IL-2 in the presence or absence of 25 ng/mL IL-12.
Bone Marrow Chimeras
Adoptive Transfer and OVA Peptide Administration 
L. Monocytogenes Infection
The recombinant LM-OVA strain was provided by M. Bevan (University of Washington). A total of 10 4 cfu LM-OVA were injected intravenously into mice after growth to log phase (OD 600 = 0.1-0.4) in brain heart infusion media (BD Biosciences) at 37 C. mice were plated in a 24-well flat-bottom plate precoated with 1 mg/ml anti-CD3 (2C11) and 1 mg/ml anti-CD28 (37.51) in medium with 500 units/ml rmIL-2. After 72 hr, cells were resuspended in retroviral supernatant containing 8 mg/ml polybrene (Sigma-Aldrich) and were centrifuged at 2500 rpm for 2 hr at 37 C, then cultured at 37 C in complete RPMI containing 500 U/ml rmIL-2 and 4-hydroxytamoxifen (Sigma-Aldrich 
Induction of EAE
